• OPEN AN ACCOUNT
Indian Indices
Nifty
25,405.30 -48.10
(-0.19%)
Sensex
83,147.97 -91.50
( -0.11%)
Bank Nifty
56,791.95 -207.25
( -0.36%)
Nifty IT
38,854.30 -24.80
( -0.06%)
Global Indices
Nasdaq
44,849.54 344.11
(0.77%)
Dow Jones
6,298.76 50.34
(0.81%)
Hang Seng
39,792.23 6.33
(0.02%)
Nikkei 225
8,823.20 48.51
(0.55%)
Forex
USD-INR
85.63 0.05
(0.05%)
EUR-INR
100.93 0.01
(0.01%)
GBP-INR
117.11 -0.50
(-0.43%)
JPY-INR
0.60 0.00
(-0.16%)

EQUITY - MARKET SCREENER

Divis Laboratories Ltd
Industry :  Pharmaceuticals - Indian - Bulk Drugs
BSE Code
ISIN Demat
Book Value()
532488
INE361B01024
561.0868795
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
DIVISLAB
82.52
182282.67
EPS(TTM)
Face Value()
Div & Yield %
83.21
2
0.44
 

rdb infrastructure & power ltd
Shri Keshav Cements & Infra Ltd - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome
Jun 02,2025
Pursuant to Regulation 30 of the SEBI (Listing Obligations & Disclosure Requirements) Regulations 2015 please find below the website link of the audio recording of analyst/investor conference call held on 02nd June 2025 at 05.00 P.M. conducted to discuss about the Companys performance for the Quarter/ Year ended 31st March 2025. The analyst/investor conference call was conducted after the meeting of Board Meeting Dt. 27th May 2025 wherein the Q4 & FY 2024-25 results were approved.